Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer's disease: a phase I/II clinical trial.

Gen Psychiatr · 2023 · PMC10582850 · PMID 37859748

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Caregivers’ worries about the patients’ neuropsychiatric symptoms seemed to be reduced (−2.4 (3.7), p=0.136, did not reach statistical significance) ( online supplemental table 2 ).

also in 111,027 other papers

a decreasing trendno p-value reported

an increasing trendno p-value reported

Furthermore, in the medium-dose arm, improvements in activities of daily living were indicated by an increasing trend in scores of ADCS-ADL and a decreasing trend in scores of ADL to some extent ( figure 5F ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.